Article

Binkhorst Lecture: Three programs offer hope for addressing cataract globally

San Francisco-Three programs in different geographic areas of the world serve as models of success in addressing cataract, the top cause of blindness globally, said David F. Chang, MD, who delivered the Binkhorst Lecture during the opening session.

San Francisco-Three programs in different geographic areas of the world serve as models of success in addressing cataract, the top cause of blindness globally, said David F. Chang, MD, who delivered the Binkhorst Lecture during the opening session.

The Aravind Eye Care System in southern India, the Tilganga Eye Centre in Kathmandu, Nepal, and Project Vision in China have made an impact by offering fast, low-tech, high-volume cataract surgery in ways that maximize the resources available in their areas, said Dr. Chang, clinical professor of ophthalmology at the University of California, San Francisco.

Patients undergoing phacoemulsification, who pay for their procedures, subsidize the care for the others, who receive manual small-incision cataract surgery (M-SICS). Most importantly, he said, the procedures are affordable, and research has shown that the complication rates are low and that M-SICS is effective at restoring functional vision in these populations.

"When you consider the reduction in life expectancy and the loss of productivity by the blind and those who care for them, there are very few medical interventions that can match cataract surgery in terms of cost effectiveness and its impact on human suffering," Dr. Chang said.

He thanked the leaders of these organizations "for their continually reminding me that, despite the fact that our own society, based on declining reimbursement, seems to value what we do less and less . . . good cataract surgeons remain one of the most precious and valuable assets for any society."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.